B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT ID: NCT02428023
Last Updated: 2016-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2500 participants
OBSERVATIONAL
2015-03-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Pain in People With Thalassemia
NCT00872339
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833
Detection Of β-thalassemia Carriers In Assiut
NCT03822585
Choroidal Thickness in Beta-thalassemia Patients
NCT04067258
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GrThalasaemia
estimation of IMT of the carotides arteries and calcium scoring
No interventions assigned to this group
GrNormal
estimation of IMT of the carotides arteries and calcium scoring
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects with Thalassemia treat will be confirmed of their treat by electrophoresis -
Exclusion Criteria
18 Years
57 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
404 General Military Hospital, Larissa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ANDREANIDIS ELIAS
Director of Cardiology Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elias Andreanidis, PhD
Role: PRINCIPAL_INVESTIGATOR
404 General Military Hospital, Larissa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
404 Military Hospital
Larissa, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
404 General Military Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.